Drug profile

The FDA adverse-event record for Meloxicam Injection

33 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Meloxicam Injection. See the species affected, top reactions, and outcomes below.

33
adverse-event reports
24.2%
death-coded share
Dog
most-reported species
10
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
33
Total Reports
8
Deaths Reported
24.2%
Death Rate

Active Ingredients

Meloxicam Injection

Administration Routes

ParenteralUnknownSubcutaneousIntravenousOther

Species Affected

Dog 18
Cat 15

Most Affected Breeds

Domestic Shorthair 10
Beagle 3
Chihuahua 2
Bichon Frise 1
Dachshund - Standard Long-haired 1
Terrier - Rat 1
Bulldog - American 1
Schnauzer - Miniature 1
Greyhound 1
Russian 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 10
Not eating 8
Other abnormal test result NOS 7
Anorexia 6
Dehydration 6
Behavioural disorder NOS 5
Vocalisation 5
Vomiting 5
Not sleeping 5
Hypoproteinaemia 5
Restlessness 4
Peritonitis 4

Outcome Breakdown

Ongoing
11 (33.3%)
Recovered/Normal
10 (30.3%)
Outcome Unknown
4 (12.1%)
Euthanized
4 (12.1%)
Died
4 (12.1%)

Meloxicam Injection Adverse Event Insights

33 reports name Meloxicam Injection; 8 recorded a death outcome (24.2% of reported events, not a population-level mortality rate). Active ingredient: Meloxicam Injection. Administration routes: Parenteral, Unknown, Subcutaneous, Intravenous.

By species: Dog (18 reports), Cat (15 reports). By breed: Domestic Shorthair (10), Beagle (3), Chihuahua (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (10), Not eating (8), Other abnormal test result NOS (7), Anorexia (6). Outcome, 33 coded reports: Ongoing leads at 33.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.